Registry of Lobbyists

Registration - In-house Corporation

MDS Inc / Stephen DeFalco, President & CEO

Registration Information

In-house Corporation name: MDS Inc
Responsible Officer Name: Stephen DeFalco, President & CEO 
Initial registration start date: 2005-08-19
Registration status: Inactive
Registration Number: 777265-5089

Version 2 of 4 (2006-02-27 to 2006-09-11)

Version 2 of 4 (2006-02-27 to 2006-09-11) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: MDS Inc
100 International Blvd
Toronto, ON  M9W 6J6
Canada
Telephone number: 416-213-4727
Fax number: 416-213-4222  
Responsible officer name and position during the period of this registration: Stephen DeFalco, President & CEO  
Description of activities: MDS Inc. has more than 8,800 highly skilled people in 27 countries. We provide a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven heath and life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease.
 
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: James Garner
Position title: Executive Vice-President & Chief Financial Officer
Public offices held: No
 
Name: Gilbert Godin
Position title: President, Pharma Services, a division of MDS (Canada) Inc.
Public offices held: No
 
Name: Kenneth Horton
Position title: Executive Vice President, Corporate Development and General Counsel
Public offices held: No
 
Name: Grant Malkoske
Position title: Vice-President Engineering & Technology (MDS Nordion)
Public offices held: No
 
Name: Edward Martell
Position title: Senior Vice-President, Quality & Regulatory Affairs
Public offices held: No
 
Name: John Mayberry
Position title: Director
Public offices held: No
 
Name: David McInnes
Position title: Vice-President, Government Affairs (MDS Nordion)
Public offices held: No
 
Name: Mary Mogford
Position title: Director
Public offices held: No
 
Name: Steven West
Position title: President, MDS Nordion, a division of MDS (Canada) Inc.
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Agriculture and Agri-Food Canada (AAFC), Canadian International Development Agency (CIDA), Canadian Nuclear Safety Commission (CNSC), Canadian Transportation Agency (CTA), Foreign Affairs and International Trade Canada (DFAITC), Hazardous Materials Information Review Commission (HMIRC), Health Canada (HC), Industry Canada, Natural Resources Canada (NRCan), Privy Council Office (PCO), Public Safety & Emergency Preparedness Canada, Transportation Safety Board of Canada (TSB)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Energy, Environment, Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
 
Subject Matter: Retrospective: - Atomic Energy of Canada Limited (AECL) - Foreign Affairs- International Trade- Transport Canada- Canada Border Services Agency- Privy Council Office- Natural Resoures Canada- Industry Canada- Canadian Nuclear Safety Commission- Canada International Development Agency- Health Canada- Science & Technology- Health Protection Branch
Subject Matter: Prospective: - Atomic Energy of Canada Limited (AECL) - Foreign Affairs- International Trade- Transport Canada- Canada Border Services Agency- Privy Council Office- Natural Resoures Canada- Industry Canada- Canadian Nuclear Safety Commission- Canada International Development Agency- Health Canada- Science & Technology- Health Protection Branch
 

Details Regarding the Identified Subject Matter

Categories Description
Grant, Contribution or Other Financial Benefit Genome Canada Grants
Policy or Program - International standards and policy relating to nuclear materials- Trade promotion- International transport practices- Trans-border Transportation Policy- Cross-border action plan- Canadian Nuclear Industry Policy- Promotion of life sciences sector- International Nuclear Policy- Health Policy in the Developing World- Product registrations- Oversight of clinical trials




Date Modified: